$BLFS News
Last published 1mo ago
- 1mo agoRGENBLFSRepligen Completes Acquisition of BioLife SolutionsGlobeNewswireWALTHAM, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN, "Repligen", or the "Company")), a life sciences company focused on bioprocessing technology leadership, today
- 3mo agoBLFSBioLife Solutions Reports Second Quarter 2026 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 3mo agoRGENBLFSRepligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation MediaGlobeNewswireFast-tracks Repligen’s leadership and customer solution offering in high-growth cell therapy market by adding BioLife’s differentiated, high-margin recurring revenue business BioLife stockholders to
- 6mo agoBLFSBioLife Solutions Reports First Quarter 2026 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 6mo agoBLFSBioLife Solutions to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
- 6mo agoBLFSBioLife Solutions Wins INTERPHEX 2026 Biotech Innovation Award for CellSeal® CryoCasePR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
- 8mo agoBLFSBioLife Solutions Reports Fourth Quarter and Full Year 2025 Financial Results from Continuing OperationsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 8mo agoBLFSBioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
- 9mo agoBLFSBioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines MarketPR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT)...
- 10mo agoBLFSBioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2025 Unaudited Revenue from Continuing OperationsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 11mo agoBLFSBioLife Solutions Unveils the Aby J. Mathew Center for Biopreservation ExcellencePR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT)...
- 11mo agoBLFSBioLife Solutions to Participate in Upcoming Investor Conferences in November and December 2025PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT)...
- 1y agoBLFSBioLife Solutions Reports Third Quarter 2025 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 1y agoBLFSBioLife Solutions to Report Third Quarter 2025 Financial Results and Business Update on November 6, 2025PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
- 1y agoBLFSBioLife Solutions Announces the Sale of its evo Cold Chain Logistics SubsidiaryPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools for the cell and gene...
- 1y agoBLFSBioLife Solutions, Inc. - Appeal, Affirmed-in-PartUS Patent Trial and Appeal Board
- 1y agoBLFSBioLife Solutions, Inc. - Appeal, Affirmed-in-PartUS Patent Trial and Appeal Board
- 1y agoBLFSBioLife Solutions, Inc. (BLFS) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoBLFSBioLife Solutions Reports Second Quarter 2025 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 1y agoBLFSBioLife Solutions Makes Strategic Investment in PluristyxPR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
- 1y agoBLFSBioLife Solutions to Report Second Quarter 2025 Financial Results and Business Update on August 7, 2025PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
- 1y agoBLFSBioLife Solutions to Participate in Upcoming Investor Conferences in May and June 2025PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
- 1y agoBLFSBioLife Solutions Updates Earnings Call InformationPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 1y agoBLFSBioLife Solutions Reports First Quarter 2025 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 1y agoBLFSBioLife Solutions to Report First Quarter 2025 Financial Results and Business Update on May 8, 2025PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
- 1y agoBLFSBioLife Solutions Acquires PanTHERA CryoSolutions to Advance Leadership as a Pure Play Bioproduction Consumables CompanyPR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the...
- 1y agoBLFSBioLife Solutions Appoints Cathy Coste as Director and Audit Committee ChairPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the...
- 1y agoBLFSBioLife Solutions Reports Fourth Quarter and Full Year 2024 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 1y agoBLFSBioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") ...
- 1y agoBLFSBioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue from Continuing OperationsPR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the...
- 1y agoBLFSRGENBioLife Solutions Appoints Tony J. Hunt to its Board of DirectorsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the...
- 1y agoBLFSBioLife Solutions Announces $6.1 million Sale of its Custom Biogenic Systems Freezer SubsidiaryPR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction tools and services for the...
- 1y agoBLFSBioLife Solutions, Inc. (BLFS) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoBLFSBioLife Solutions Reports Third Quarter 2024 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 1y agoBLFSBioLife Solutions Announces $73 Million Sale of its SciSafe Biostorage SubsidiaryPR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of cell processing tools and services for the...
- 2y agoBLFSBioLife Solutions to Report Third Quarter 2024 Financial Results and Business Update on November 12, 2024PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapies...
- 2y agoBLFSBioLife Solutions, Inc. (BLFS) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoBLFSBioLife Solutions Reports Second Quarter 2024 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the...
- 2y agoBLFSBioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") ...
- 2y agoBLFSBioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in VancouverPR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of bioproduction tools and services for the cell and gene therapy (CGT) and broader...
- 2y agoBLFSBioLife Solutions, Inc. (BLFS) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoBLFSBioLife Solutions Reports First Quarter 2024 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the...
- 2y agoBLFSBioLife Solutions to Report First Quarter 2024 Financial Results and Business Update on May 9, 2024PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") ...
- 2y agoBLFSBioLife Solutions Announces the Divestiture of its Stirling Freezer BusinessPR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the...
- 2y agoBLFSBioLife Solutions to Present at TD Cowen and Key Bank Investor ConferencesPR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") ...
- 2y agoBLFSBioLife Solutions, Inc. (BLFS) Q4 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoBLFSBioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and...
- 2y agoBLFSBioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024PR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") ...
- 2y agoBLFSBioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited RevenuePR NewswireBioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the...
- 3y agoBLFSBioLife Solutions Reports Third Quarter 2023 Financial ResultsPR NewswireBioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and...